A Study of Drug-Drug Interaction Between Danoprevir/Low-Dose Ritonavir and Raltegravir in Healthy Volunteers
Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
This open-label, multiple dose, single sequence crossover study will evaluate the drug-drug
interaction between danoprevir/low-dose ritonavir and raltegravir in healthy volunteers.
Subjects will receive raltegravir on Days 1-4 and, after a washout period of 3 days,
danoprevir and low-dose ritonavir on Days 8-21, in combination with raltegravir on Days
18-21.